31.10.2014 MediClin AG  DE0006595101

DGAP-News: MediClin AG: Group sales and Group operting result increased - Earnings forecast for the 2014 financial year has been slightly raised


 
DGAP-News: MediClin AG / Key word(s): 9-month figures/9-month figures MediClin AG: Group sales and Group operting result increased - Earnings forecast for the 2014 financial year has been slightly raised 31.10.2014 / 14:30 --------------------------------------------------------------------- MediClin: Group sales and Group operting result increased - Earnings forecast for the 2014 financial year has been slightly raised Offenburg, October 31, 2014 - In the first nine months of 2014 MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 402.8 mill. (9M 2013: EUR 389.7 mill.) thus being EUR 13.1 mill. or 3.4 % above the previous year's value. The post-acute segment contributed EUR 11.1 mill. and the acute segment EUR 2.3 mill. to the sales increase. The occupancy rate of the Group improved to 87.6 % (9M 2013: 85.4 %). Compared to the nine-month-period 2013 the Group operating result improved by EUR 10.0 mill. from EUR 2.2 mill. to EUR 12.2 mill. and the result after tax attributable to shareholders of MediClin AG by EUR 9.4 mill. from EUR -1.4 mill. to EUR 8.0 mill. Decisive for the good development in the Group was the continuing positive sales and earnings development of the post-acute segment in the 3rd quarter compared with the previous year as well as with the 1st and 2nd quarter 2014 so that in the 3rd quarter a Group operating result of EUR 9.1 mill. could be achieved. Particularly well performed the clinics of the post-acute segment which offer besides rehabilitation services also services of acute-neurology and acute-psychosomatic - the focus of investments was set on this expansion in 2012 and 2013. In the acute segment the segment result amounted to EUR 6.7 mill., which was EUR 0.7 mill. above the previous year's value. As of September 30, 2014 cash and cash equivalents were EUR 24.6 mill. (30.09.2013: EUR 16.3 mill.). In the first nine months of 2014 EUR 14.2 mill. (gross) was invested in non-current assets, thus being EUR 0.8 mill. above previous year's level. The equity ratio was 47.9 % (30.09.2013: 48.6 %). In the first nine months of 2014 MediClin employed on average 6,405 employees, measured in full-time employees (9M 2013: 6,372 full-time employees). Sales forecast for the 2014 financial year is confirmed - earnings forecast has been slightly raised The business development of the first nine months 2014 leads to the expectation that the predicted sales targets of the Group (+3.0 %) and of the segments post-acute (+4.5 % to +5.0 %) and acute (+1.0 % to +1.5%) will be achieved. The earning targets of EUR 4 to 6 mill. for the Group operating result will be slightly increased. The interim report as of September 30, 2014 will be available in German and English from November 10, 2014 under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 10 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,800 employees. MediClin ─ a company of the Asklepios Group --------------------------------------------------------------------- 31.10.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 294427 31.10.2014


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,560 Halten 121,60
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
9,85 19,18 0,51 19,25
KBV KCV KUV EV/EBITDA
0,62 1,56 0,17 1,43
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-1,04% -7,04% -6,57% -22,42%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED